## RJF: Raymond James Financial, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 2.8% below STRENGTH zone (3.0-6.0%); PEG 1.35 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($158.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Is Raymond James Financial Stock Underperforming the Dow?**
- Source: Markets Financial Content | 20251209T130834 | Neutral | Relevance: 99%
-  Raymond James Financial (RJF) has a market capitalization of $32.3 billion and has seen its stock decline 7.6% from its 52-week high. Despite stronger Q4 2025 results and a "Moderate Buy" consensus rating from analysts with an indicated 12.3% premium to current levels, RJF has underperformed the Dow Jones Industrials Average over the past three months and year-to-date. However, it has outperformed its rival, Blackstone Inc. (BX).

**2. Amundi Has $62 Million Position in Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251209T083449 | Somewhat-Bullish | Relevance: 98%
-  Amundi significantly reduced its stake in Raymond James Financial, Inc. by 47.7% during the second quarter, now holding 391,970 shares valued at $62 million. Despite this reduction, several other institutional investors increased their positions in RJF. Analysts have provided mixed ratings, with a consensus "Hold" and an average target price of $177.20 for Raymond James Financial.

**3. Raymond James (RJF) Is Up 5.4% After Boosting Payouts and Launching US$2 Billion Buyback Program**
- Source: Simply Wall Street | 20251209T113116 | Bullish | Relevance: 98%
-  Raymond James Financial (RJF) announced an 8% increase in its quarterly dividend to US$0.54 per share and authorized a new US$2.00 billion open-ended share repurchase program. These strategic moves are aimed at returning more cash directly to common shareholders and simplifying the firm's capital structure. The expanded buyback program provides flexibility to manage share count, particularly during periods of modest earnings growth or market volatility.

**4. Marshall Wace LLP Acquires 390,821 Shares of Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251207T111346 | Bullish | Relevance: 98%
-  Marshall Wace LLP significantly increased its stake in Raymond James Financial, Inc. ($RJF) by 824.7% in Q2, purchasing 390,821 additional shares to now own a total of 438,213 shares valued at approximately $67.21 million. Raymond James Financial ($RJF) recently beat earnings expectations, reporting EPS of $3.11 against an anticipated $2.83, and has increased its quarterly dividend to $0.54 per share. Several other hedge funds have also adjusted their positions in the company, with 83.83% of the stock currently held by institutional investors.

**5. Is Raymond James Financial Stock Underperforming the Dow?**
- Source: Barchart.com | 20251209T125157 | Neutral | Relevance: 97%
-  Raymond James Financial (RJF) has underperformed the Dow Jones Industrials Average ($DOWI) over the past three months, year-to-date, and over the past 52 weeks. Despite reporting stronger Q4 2025 results and positive analyst sentiment with a "Moderate Buy" rating, the stock has struggled against the broader market while still outperforming rival Blackstone Inc.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.00M) |
| Sells | 15 ($0.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 11.1% (-1.4%)
- Blackrock Inc.: 7.4% (-2.9%)
- JPMORGAN CHASE & CO: 5.9% (+108.2%)
- Primecap Management : 4.9% (-3.7%)
- Wellington Managemen: 4.6% (-5.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Share repurchase program provides demand floor and EPS support.
- Momentum building: MRS_10 improving +2.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.35 suggests fair value with growth premium. Quality metrics strong (margin 15%). Institutional flow bullish (1 buying vs 9 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.9B |
| Beta | 1.01 |
| 52W Range | $117.57 - $177.66 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.35 |
| Forward P/E | 12.2 |
| Current P/E | 13.7 |
| YoY Growth | 11.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.1% to 2.8% (+2.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.2pp (needs >3.0% for momentum thesis). MRS_5 at 1.2% confirms short-term momentum alignment. Outperforming sector by 3.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.35), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.82% (CS: 83) | Neutral |
| RSI_14 | 62.1 | Neutral |
| MACD Histogram | 1.35 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.024x | Above |
| vs SMA200 | 1.065x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $164.93
- **Stop Loss:** $158.29 (4.0% risk)
- **Target:** $171.57 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 75
- **Position Value:** $12,369.75
- **Portfolio %:** 12.37%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-28 (Est: $2.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.11 | +10.0% |
| 2025Q2 | $2.36 | $2.18 | -7.5% |
| 2025Q1 | $2.44 | $2.42 | -0.7% |
| 2024Q4 | $2.69 | $2.93 | +8.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*